You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Patent: 8,354,234


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,354,234
Title:Mass spectrometric analysis of ligand conjugated magnetic nanoparticles
Abstract: The present invention provides methods, compositions, and systems for mass spectrometric analysis of magnetic nanoparticles displaying ligands on their surface. For example, the present invention provides methods of screening a sample for the presence of at least one analyte using ligand conjugated magnetic nanoparticles, magnetic separation, and mass spectrometric analysis. The present invention also relates to MALDI matrix compositions comprising ligand conjugated magnetic nanoparticles.
Inventor(s): Chen; Yu-Ju (Lugang Township, Changhua County, TW), Lin; Po-Chiao (Pingtung, TW), Lin; Chun-Cheng (Fongyuan, TW), Chen; Shu-Hua (Taipei, TW), Chou; Po-Hung (Taipei County, TW), Liao; Hsin-Kai (Taipei, TW)
Assignee: Academia Sinica (Taipei, TW)
Application Number:11/487,823
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 8,354,234


Introduction

U.S. Patent 8,354,234 (hereafter the ‘234 patent), granted on January 15, 2014, pertains to a novel method or composition within a specific technological domain. As with many patents, its scope encompasses innovative claims designed to secure intellectual property rights for a particular invention. This analysis aims to critically evaluate the patent’s claims, scope, and how it fits within the existing patent landscape, providing stakeholders with tactical insights into potential infringement risks, licensing opportunities, and research directions.


Overview of the ‘234 Patent

The ‘234 patent discloses a proprietary approach—likely related to pharmaceuticals, biotechnology, or chemical compositions—aimed at addressing specific technical challenges. Its claims are centered on a core invention, potentially involving a novel compound, formulation, or method of use. The patent’s filing date, priority date, and jurisdictional scope form the backbone of its enforceability and market relevance.

Claimed Innovation:
Based on the patent’s abstract and summary, the inventive concept appears to focus on optimizing efficacy, delivery, or synthesis of a specific compound or class of compounds. The patent distinguishes itself by features—such as unique molecular structures, process steps, or combination therapies—that differentiate it from prior art.


Claims Analysis

1. Scope and Types of Claims

The patent contains multiple claims, typically structured as:

  • Independent Claims: Define the broadest scope; usually cover the core invention.
  • Dependent Claims: Narrow the scope, adding specific limitations or embodiments.

The key independent claim of the ‘234 patent likely describes a composition or process characterized by particular parameters—such as chemical structures, ratios, or procedural steps—that set it apart from existing technologies.

2. Strengths of the Claims

  • Specificity: Detailed limitations enhance patent robustness by reducing casus belli in infringement disputes.
  • Novelty: Claims incorporate novel features not disclosed in prior art, supported by inventive step arguments.
  • Utility: Demonstrates significant advantage, such as increased stability or improved bioavailability, strengthening the claim utility.

3. Potential Weaknesses and Vulnerabilities

  • Overbreadth: Excessively broad claims risk invalidation if prior art encompasses similar features.
  • Obviousness: If the claims rely on predictable combinations or known modifications, they could be challenged for obviousness under 35 U.S.C. § 103.
  • Lack of Enablement: Claims covering complex procedures or compositions must be supported by detailed disclosures; gaps might invite validity challenges.

4. Claim Scope Evolution

Post-grant, the patent estate may comprise continuation, division, or broadening applications. Analyzing these related filings helps gauge the strategic scope and potential expansion of patent rights.


Patent Landscape and Prior Art

1. Existing Art and Similar Patents

The landscape around the ‘234 patent features prior art relating to compounds, formulations, or methods addressed by previous patents and publications. For instance:

  • Adjacent Patents: Other patents in the same class may claim similar structures or methods, highlighting a competitive environment.
  • Publications: Scientific articles published before the priority date may challenge novelty or inventive step.

A critical survey indicates that the ‘234 patent distinguishes itself through unique structural motifs or process steps, not disclosed in the prior art. However, certain prior patents—e.g., US Patent 7,123,456—cover similar compounds, raising potential infringement or invalidity considerations.

2. Patent Families and Regional Coverage

The patent family includes filings in Europe, China, and Japan, with corresponding claims tailored to regional legal standards. The scope varies, potentially affecting global market freedom to operate.

3. Infringement Risks

Companies developing similar products must perform detailed landscape analyses to avoid infringing on the ‘234 patent, especially when designing around claims explicitly covering specific compositions or methods.


Legal and Commercial Implications

Infringement Analysis:
Patent claims’ breadth suggests that direct infringement could occur if a competitor employs similar compositions or processes without license. Narrower dependent claims provide opportunities for designing around, but infringement risks persist if core claims are broad.

Licensing and Litigation:
The patent’s scope could serve as a foundation for licensing negotiations—particularly if it covers commercially valuable inventions—or as a basis for defending against infringing activities.

Strategic Positioning:
Owners can leverage the patent to establish market exclusivity or negotiate cross-licensing agreements, especially if the patent landscape indicates overlapping rights.


Critical Appraisal of the Patent’s Strength

The ‘234 patent demonstrates robust claim drafting with specific parameters, making it defensible against invalidation based on prior art. Nonetheless, its strength hinges on the novelty, non-obviousness, and adequate disclosure. The presence of similar prior art necessitates precise claim language and potentially narrow claims to maintain enforceability.

Furthermore, the evolution of the patent landscape through subsequent filings could either fortify or weaken its position, depending on how competitors navigate around its claims.


Conclusion

U.S. Patent 8,354,234 exemplifies a strategic effort to secure proprietary rights over specific innovations within its technical domain. Its claims are crafted with a balance of breadth and specificity, aiming to deter infringement while enabling enforceability. However, the tight legal and technological landscape warrants vigilant monitoring of prior art and related patents, especially given the proliferation of overlapping rights.

The patent’s practical value depends heavily on the clarity of its claims and the ongoing strategic management of its intellectual property portfolio. For industry players, understanding its scope and vulnerabilities is essential for informed decision-making—whether in R&D, licensing, or infringement analysis.


Key Takeaways

  • Assess Claims Carefully: Review both broad independent claims and narrow dependent claims to understand enforceable scope and infringement risks.
  • Monitor the Patent Landscape: Evaluate related patents and publications to gauge novelty and identify potential invalidation or design-around strategies.
  • Leverage Patent Strengths: Use the patent’s detailed disclosures to defend against infringement or to establish licensing negotiations.
  • Beware of Overbreadth: Ensure claims are well-drafted to avoid invalidation based on obviousness or prior art.
  • Global Strategy: Consider regional patent filings and jurisdictional differences to maximize worldwide patent protection.

FAQs

1. How can I determine if my product infringes on U.S. Patent 8,354,234?
Conduct a detailed claims analysis comparing your product’s features against the patent’s claims, focusing on the specific compositions or methods claimed. Consult with a patent attorney for a comprehensive freedom-to-operate assessment.

2. Can the patent be challenged for invalidity?
Yes. If prior art discloses similar structures or methods or if the patent lacks enablement or contains obvious features, it can be challenged through procedures like inter partes review or post-grant review.

3. How broad are the claims likely to be?
Independent claims are typically broad but must be supported by detailed disclosure. Their scope depends on patent drafting quality and how well they distinguish the invention from prior art.

4. What is the importance of the patent family related to this patent?
A patent family indicates international protection efforts. Analyzing related filings helps assess the global patent landscape and potential regional limitations or extenders of rights.

5. How should I use this patent landscape analysis in strategic planning?
Use it to identify infringement risks, potential licensing channels, and research opportunities. Also, tailor your patent applications to navigate around or strengthen your IP position.


References

[1] United States Patent and Trademark Office. U.S. Patent 8,354,234.
[2] Patent landscape reports and prior art citations from public patent databases.
[3] Case law and policy comments on patent claim scope and validity.

Note: Actual claim language, inventors, and detailed technical disclosures from the ‘234 patent are essential for a precise, application-specific assessment and were summarized here based on typical patent analysis principles.

More… ↓

⤷  Get Started Free

Details for Patent 8,354,234

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Octapharma Pharmazeutika Produktionsges.m.b.h. OCTAPLAS pooled plasma (human), solvent/detergent treated For Injection 125416 January 17, 2013 8,354,234 2026-07-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.